TP53 and cancer: It would therefore be interesting to investigate whether cancers with cooperativity mutant p53 (and maybe other non-hotspot LOF mutants with preserved pro-senescence activity) are sensitized to standard cytotoxic chemotherapy by senolytic drugs.